van Lent P L, van den Bersselaar L A, van den Hoek A E, van de Loo A A, van den Berg W B
Department of Rheumatology, University Hospital St. Radboud, Nijmegen, The Netherlands.
Am J Pathol. 1992 Jun;140(6):1451-61.
A novel cationic immune-complex-mediated arthritis (ICA) model was developed in mice. The highly cationic protein lysozyme was coupled to poly-L-lysine (PLL) and injected intra-articularly into the knee joint of the mouse, shortly after systemic administration of specific antibodies. A vehement joint inflammation developed, characterized by severe joint swelling and the influx of predominantly polymorphonuclear (PMN) leukocyte. Unique properties were combined in this protein. First, an excellent retention of the antigen in joint structures was found, facilitating sufficient IC formation in the synovial tissue and at the cartilage surface. Secondly, PLL.lysozyme appeared to be a potent inducer of interleukin-1 (IL-1). Similar IL-1 production was measured at 6 hours, in both immune or nonimmune mice. Neutralization with antibodies against either IL-1 alpha or IL-1 beta revealed that IL-1 alpha was the dominant cytokine. Resident cells were responsible for this IL-1 production since a comparable IL-1 signal was measured after intra-articular injection of PLL.lys in neutropenic mice. We further investigated whether IL-1 and complement factors were involved in the onset of this ICA. Neutralizing the IL-1 production with antibodies directed against IL-1 alpha and beta showed a significant decrease in joint swelling. Complement depletion by cobra venom factor also prevented the onset of arthritis for the greater part. Only a minor swelling remained at 6 hours after eliciting arthritis, which was similar to the swelling after injecting the antigen alone and probably reflects IL-1 mediated inflammation. In this study, the authors show a synergistic action of IL-1 and complement in the onset of cationic ICA. Unique properties of the antigen such as excellent retention and its ability to induce IL-1 are combined within one molecule and make this antigen arthritogenic in the presence of antibodies and complement activation.
在小鼠中建立了一种新型阳离子免疫复合物介导的关节炎(ICA)模型。将高度阳离子化的蛋白质溶菌酶与聚-L-赖氨酸(PLL)偶联,并在全身给予特异性抗体后不久,关节内注射到小鼠膝关节中。出现了剧烈的关节炎症,其特征为严重的关节肿胀和主要是多形核(PMN)白细胞的流入。这种蛋白质具有独特的特性。首先,发现抗原在关节结构中保留良好,有利于在滑膜组织和软骨表面形成足够的免疫复合物。其次,PLL-溶菌酶似乎是白细胞介素-1(IL-1)的有效诱导剂。在免疫或非免疫小鼠中,6小时时均检测到类似的IL-1产生。用抗IL-1α或IL-1β抗体进行中和表明,IL-1α是主要的细胞因子。驻留细胞负责这种IL-1的产生,因为在中性粒细胞减少的小鼠关节内注射PLL-溶菌酶后测量到了类似的IL-1信号。我们进一步研究了IL-1和补体因子是否参与了这种ICA的发病。用针对IL-1α和β的抗体中和IL-1的产生,关节肿胀明显减轻。眼镜蛇毒因子消耗补体也在很大程度上预防了关节炎的发作。引发关节炎后6小时仅残留轻微肿胀,这与单独注射抗原后的肿胀相似,可能反映了IL-1介导的炎症。在这项研究中,作者表明IL-1和补体在阳离子ICA发病中具有协同作用。抗原的独特特性,如良好的保留和诱导IL-1的能力,结合在一个分子内,使其在存在抗体和补体激活的情况下具有致关节炎性。